Hormone Level Assessment in Female Patients

Clinical Indications for Hormone Testing

• The American College of Obstetricians and Gynecologists recommends ordering hormone levels in female patients who present with menstrual irregularities, such as polymenorrhea, oligomenorrhea, or amenorrhea, due to the potential for underlying reproductive endocrine disorders 1
• The Endocrine Society suggests ordering hormone levels for patients with primary amenorrhea, defined as no menarche by age 16, to rule out potential causes such as genetic disorders or anatomical abnormalities 5
• Baseline LH, FSH, and estradiol levels should be assessed at age 13 years in at-risk patients, such as those with a family history of reproductive endocrine disorders, to monitor for potential issues with puberty 6
• Hormone tests, including LH and FSH, should be ordered after 12 months of regular unprotected intercourse without conception to evaluate for potential infertility causes 1
• The American Academy of Family Physicians recommends ordering hormone levels for patients with signs of hyperandrogenism, such as hirsutism or acne with menstrual irregularity, to rule out potential causes such as polycystic ovary syndrome (PCOS) 1, 2
• Prolactin levels should be ordered for patients with galactorrhea, defined as spontaneous milk expression in non-lactating women, to rule out potential causes such as prolactinoma 1
• The North American Menopause Society recommends ordering hormone levels for patients with suspected premature ovarian insufficiency (POI), defined as secondary amenorrhea in women under 40 years, to confirm the diagnosis 7

Special Populations Requiring Hormone Testing

• The American Society of Clinical Oncology recommends ordering hormone levels in female cancer survivors treated with alkylating agents or radiation to monitor for potential reproductive endocrine disorders 8, 7
• The American Academy of Neurology recommends ordering hormone levels in women with epilepsy who have menstrual irregularities or are taking valproate therapy, which may increase the risk of PCOS 1, 2, 3

Specific Hormone Tests and Timing

• For PCOS evaluation, LH and FSH levels should be measured between days 3-6 of the cycle, and glucose/insulin ratio should be measured in the morning 1
• For ovarian reserve assessment, anti-Müllerian hormone (AMH) levels can be measured at any time, as they do not vary by menstrual day or exogenous hormones 6, 8
• For premature ovarian insufficiency diagnosis, FSH and estradiol measurements should be performed after stopping oral contraceptives/hormone replacement therapy, ideally after two months, and two elevated serum FSH levels in the menopausal range are required for diagnosis 7

Common Pitfalls to Avoid

• Measuring hormone levels during use of hormonal contraceptives or hormone replacement therapy may mask underlying abnormalities, and levels should be interpreted with caution 5, 7
• Failing to consider diurnal variations, such as measuring testosterone in the morning, may lead to inaccurate results 9
• Assuming regular menstrual cycles indicate normal fertility in cancer survivors may lead to delayed diagnosis of reproductive endocrine disorders 5